DATED 4th May 2022 and EMPLOYMENT AGREEMENTEmployment Agreement • May 4th, 2022 • Adaptimmune Therapeutics PLC • Biological products, (no disgnostic substances)
"Board" the "AT plc Board"the "Board" means the board of directors from time to time of Adaptimmune Therapeutics plc and includes any committee of the board of directors duly appointed by it; means the board of directors from time to time of the Company and includes any committee of the board of directors duly appointed by it; the "Company Share Option Scheme" means the share option scheme or schemes operated by the Company or any Group Company from time to time; “Competitor or Potential Competitor” means any firm, company or business organisation (including in each case any entity which directly or indirectly controls, is controlled by, or is under common control by any firm, company or business organisation) which, controls, provides or owns (i) any clinical or development program utilizing a T-cell therapy; (ii) any clinical or development program utilizing a T-cell transfected or transduced with the genetic sequence for any TCR or any CAR-T cell; or (iii) any manufactur
